These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 1534398

  • 1. Complexes containing the retinoblastoma gene product recognize different DNA motifs related to the E2F binding site.
    Ouellette MM, Chen J, Wright WE, Shay JW.
    Oncogene; 1992 Jun; 7(6):1075-81. PubMed ID: 1534398
    [Abstract] [Full Text] [Related]

  • 2. Regulation of adenovirus 12 E1A transcription: E2F and ATF motifs in the E1A promoter bind nuclear protein complexes including E2F1, DP-1, cyclin A and/or RB and mediate transcriptional (auto)activation.
    Kirch HC, Pützer B, Schwabe G, Gnauck HK, Schulte Holthausen H.
    Cell Mol Biol Res; 1993 Jun; 39(8):705-16. PubMed ID: 7951410
    [Abstract] [Full Text] [Related]

  • 3. E2F-dependent regulation of human MYC: trans-activation by cyclins D1 and A overrides tumour suppressor protein functions.
    Oswald F, Lovec H, Möröy T, Lipp M.
    Oncogene; 1994 Jul; 9(7):2029-36. PubMed ID: 8208548
    [Abstract] [Full Text] [Related]

  • 4. A new component of the transcription factor DRTF1/E2F.
    Girling R, Partridge JF, Bandara LR, Burden N, Totty NF, Hsuan JJ, La Thangue NB.
    Nature; 1993 Mar 04; 362(6415):83-7. PubMed ID: 8446173
    [Abstract] [Full Text] [Related]

  • 5. Rb may act as a transcriptional co-activator in undifferentiated F9 cells.
    Bocco JL, Reimund B, Chatton B, Kedinger C.
    Oncogene; 1993 Nov 04; 8(11):2977-86. PubMed ID: 8414500
    [Abstract] [Full Text] [Related]

  • 6. The p107 tumor suppressor induces stable E2F DNA binding to repress target promoters.
    O'Connor RJ, Schaley JE, Feeney G, Hearing P.
    Oncogene; 2001 Apr 05; 20(15):1882-91. PubMed ID: 11313936
    [Abstract] [Full Text] [Related]

  • 7. Adenovirus E1a prevents the retinoblastoma gene product from complexing with a cellular transcription factor.
    Bandara LR, La Thangue NB.
    Nature; 1991 Jun 06; 351(6326):494-7. PubMed ID: 1710781
    [Abstract] [Full Text] [Related]

  • 8. A direct role of transcription factor E2F in c-myc gene expression during granulocytic and macrophage-like differentiation of HL60 cells.
    Ishida S, Shudo K, Takada S, Koike K.
    Cell Growth Differ; 1995 Mar 06; 6(3):229-37. PubMed ID: 7794791
    [Abstract] [Full Text] [Related]

  • 9. Dual control of myc expression through a single DNA binding site targeted by ets family proteins and E2F-1.
    Roussel MF, Davis JN, Cleveland JL, Ghysdael J, Hiebert SW.
    Oncogene; 1994 Feb 06; 9(2):405-15. PubMed ID: 8290253
    [Abstract] [Full Text] [Related]

  • 10. Transient accumulation of retinoblastoma/E2F-1 protein complexes correlates with the onset of neuronal differentiation in the developing quail neural retina.
    Kastner A, Espanel X, Brun G.
    Cell Growth Differ; 1998 Oct 06; 9(10):857-67. PubMed ID: 9790497
    [Abstract] [Full Text] [Related]

  • 11. Regulation of E2F-1 gene expression by p130 (Rb2) and D-type cyclin kinase activity.
    Johnson DG.
    Oncogene; 1995 Nov 02; 11(9):1685-92. PubMed ID: 7478595
    [Abstract] [Full Text] [Related]

  • 12. Mechanism of active transcriptional repression by the retinoblastoma protein.
    Weintraub SJ, Chow KN, Luo RX, Zhang SH, He S, Dean DC.
    Nature; 1995 Jun 29; 375(6534):812-5. PubMed ID: 7596417
    [Abstract] [Full Text] [Related]

  • 13. Adenovirus E4 open reading frame 4-induced dephosphorylation inhibits E1A activation of the E2 promoter and E2F-1-mediated transactivation independently of the retinoblastoma tumor suppressor protein.
    Mannervik M, Fan S, Ström AC, Helin K, Akusjärvi G.
    Virology; 1999 Apr 10; 256(2):313-21. PubMed ID: 10191196
    [Abstract] [Full Text] [Related]

  • 14. Analysis of the human proopiomelanocortin gene promoter in a small cell lung carcinoma cell line reveals an unusual role for E2F transcription factors.
    Picon A, Bertagna X, de Keyzer Y.
    Oncogene; 1999 Apr 22; 18(16):2627-33. PubMed ID: 10353606
    [Abstract] [Full Text] [Related]

  • 15. Isolation and initial characterization of the BRCA2 promoter.
    Davis PL, Miron A, Andersen LM, Iglehart JD, Marks JR.
    Oncogene; 1999 Oct 28; 18(44):6000-12. PubMed ID: 10557089
    [Abstract] [Full Text] [Related]

  • 16. Association of Pur alpha and E2F-1 suppresses transcriptional activity of E2F-1.
    Darbinian N, Gallia GL, Kundu M, Shcherbik N, Tretiakova A, Giordano A, Khalili K.
    Oncogene; 1999 Nov 04; 18(46):6398-402. PubMed ID: 10597240
    [Abstract] [Full Text] [Related]

  • 17. Characterization of an E2F-p130 complex formed during growth arrest.
    Corbeil HB, Branton PE.
    Oncogene; 1997 Aug 07; 15(6):657-68. PubMed ID: 9264406
    [Abstract] [Full Text] [Related]

  • 18. Isolation and characterization of a chicken homolog of the E2F-1 transcription factor.
    Pasteau S, Loiseau L, Arnaud L, Trembleau A, Brun G.
    Oncogene; 1995 Oct 19; 11(8):1475-86. PubMed ID: 7478572
    [Abstract] [Full Text] [Related]

  • 19. Retinoblastoma protein switches the E2F site from positive to negative element.
    Weintraub SJ, Prater CA, Dean DC.
    Nature; 1992 Jul 16; 358(6383):259-61. PubMed ID: 1321348
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.